These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 32796449

  • 1. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
    Gains JE, Aldridge MD, Mattoli MV, Bomanji JB, Biassoni L, Shankar A, Gaze MN.
    Nucl Med Commun; 2020 Nov; 41(11):1169-1177. PubMed ID: 32796449
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B, Asopa R, Basu S.
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [Abstract] [Full Text] [Related]

  • 5. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
    Win Z, Al-Nahhas A, Towey D, Todd JF, Rubello D, Lewington V, Gishen P.
    Nucl Med Commun; 2007 May; 28(5):359-63. PubMed ID: 17414885
    [Abstract] [Full Text] [Related]

  • 6. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
    Kong G, Hofman MS, Murray WK, Wilson S, Wood P, Downie P, Super L, Hogg A, Eu P, Hicks RJ.
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):87-96. PubMed ID: 26296147
    [Abstract] [Full Text] [Related]

  • 7. Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
    Alexander N, Vali R, Ahmadzadehfar H, Shammas A, Baruchel S.
    Curr Radiopharm; 2018 Mar; 11(1):14-21. PubMed ID: 29243585
    [Abstract] [Full Text] [Related]

  • 8. Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
    Fathpour G, Jafari E, Hashemi A, Dadgar H, Shahriari M, Zareifar S, Jenabzade AR, Vali R, Ahmadzadehfar H, Assadi M.
    Clin Nucl Med; 2021 Jul 01; 46(7):540-548. PubMed ID: 33782280
    [Abstract] [Full Text] [Related]

  • 9. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    Velikyan I, Sundin A, Sörensen J, Lubberink M, Sandström M, Garske-Román U, Lundqvist H, Granberg D, Eriksson B.
    J Nucl Med; 2014 Feb 01; 55(2):204-10. PubMed ID: 24379222
    [Abstract] [Full Text] [Related]

  • 10. 68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use.
    Maaz AUR, O'Doherty J, Djekidel M.
    J Nucl Med Technol; 2021 Sep 01; 49(3):265-268. PubMed ID: 33820858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
    Gains JE, Bomanji JB, Fersht NL, Sullivan T, D'Souza D, Sullivan KP, Aldridge M, Waddington W, Gaze MN.
    J Nucl Med; 2011 Jul 01; 52(7):1041-7. PubMed ID: 21680680
    [Abstract] [Full Text] [Related]

  • 13. [18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study.
    Samim A, Blom T, Poot AJ, Windhorst AD, Fiocco M, Tolboom N, Braat AJAT, Viol SLM, van Rooij R, van Noesel MM, Lam MGEH, Tytgat GAM, de Keizer B.
    Eur J Nucl Med Mol Imaging; 2023 Mar 01; 50(4):1146-1157. PubMed ID: 36504277
    [Abstract] [Full Text] [Related]

  • 14. 68Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET/CT and 123I-MIBG SPECT/CT.
    Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Url C, Riechelmann H, Sprinzl GM, Thomé C, Treglia G, Kjaer A, Fraedrich G, Virgolini IJ.
    Nucl Med Biol; 2019 Apr 01; 71():47-53. PubMed ID: 31152973
    [Abstract] [Full Text] [Related]

  • 15. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
    Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK.
    J Clin Oncol; 2009 Nov 10; 27(32):5343-9. PubMed ID: 19805691
    [Abstract] [Full Text] [Related]

  • 16. 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
    Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y.
    J Nucl Med; 2021 Jan 10; 62(1):43-47. PubMed ID: 32414950
    [Abstract] [Full Text] [Related]

  • 17. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J, Codreanu I, Servaes S, Zhuang H.
    Nucl Med Commun; 2012 Nov 10; 33(11):1134-7. PubMed ID: 22825037
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
    Gains JE, Sebire NJ, Moroz V, Wheatley K, Gaze MN.
    Eur J Nucl Med Mol Imaging; 2018 Mar 10; 45(3):402-411. PubMed ID: 29043399
    [Abstract] [Full Text] [Related]

  • 19. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.
    Hell J Nucl Med; 2015 Mar 10; 18(1):19-24. PubMed ID: 25679074
    [Abstract] [Full Text] [Related]

  • 20. The Complementary Role of 68Ga-DOTATATE PET/CT in Neuroblastoma.
    Telli T, Lay Ergün E, Volkan Salanci B, Özgen Kiratli P.
    Clin Nucl Med; 2020 Apr 10; 45(4):326-329. PubMed ID: 31977455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.